We are part of the CSL Limited group of companies. See how we're Driven by Our Promise.
We collaborate with rare disease organizations to promote quality medical care and services.
We offer a variety of support programs and activities for the patients we serve.
We also aim to make sure that nothing holds you back from getting the therapies you need.
Our product portfolio focuses on innovation in new products, improved products and manufacturing expertise.
A clinical trial is a research study that is done to find out if medical treatments can improve people’s health.
We work every day as if someone’s life depends on it, because it does.
We manufacture products to treat a number of rare diseases.
Help us deliver on our promise to save lives and protect the health of people.
Diversity and inclusion are top priorities for CSL Behring.
Q&A with CSL’s Chief Risk Officer Karen Neave.
CSL’s Executive Vice President and Head of R&D offers advice for professional development.
It’s lights, camera, action as CSL chief Paul Perreault films employee messages in our U.S. studio.
Tapping all sources of data gives a fuller picture of patient experience.
A Q & A with Chief Communications Officer Anthony Farina.
CEO and Managing Director sits down with NPR affiliate to discuss evolving industry.
CSL Behring opens regional HQ in iconic desert city.
CSL CEO Paul Perreault highlights ongoing partnership during PSU appearance.
How can we improve access to treatment for patients?
Why improving access to care is on my mind this February – and every day.
Expanded coverage in 3 states expected to help those with rare and serious diseases.
Healthy volunteers and rare disease patients participate in important research.
Popular search terms:
Americas
Asia Pacific
Middle East
Europe
